Dr. Michael W. McDermott, MD

Dr. McDermott practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. McDermott's NPI, 1972695195, was assigned on September 28, 2006. Dr. McDermott graduated from University of Toronto Faculty of Medicine in 1982. Dr. McDermott holds Florida license ME143472.

Dr. McDermott's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. McDermott's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. McDermott to 1 more breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McDermott practices, 3 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. McDermott's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. McDermott is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. McDermott's licenses on file in 2 states: Florida and California.

Dmand AI lists craniotomy among the conditions Dr. McDermott treats.

CMS data shows 73 Medicare services from Dr. McDermott across 5 procedure codes in 2024, for 67 Medicare patients. Medicare paid $19,076 for them.

CMS counts 67 Medicare patients who saw Dr. McDermott in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McDermott's median patient age at 67, with 66% women.

In 2019, Dr. McDermott wrote 27 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $712 in total drug cost. In 2018, CMS named 89 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. McDermott for performance year 2024, reported through an alternative payment model (APM). Dr. McDermott accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McDermott as offering telehealth.

Dmand AI links 622 papers to Dr. McDermott, published from 2002 to 2025. 2021 was the busiest year, with 27. The most frequent topics are Brain Neoplasms, Meningioma and Meningeal Neoplasms. Dr. McDermott has published most often in J Neurosurg. Dr. McDermott's most frequent co-authors are Mitchel S. Berger, MD, Philip V. Theodosopoulos, MD and Manish Kumar Aghi, MD, PhD.

Dmand AI links Dr. McDermott to 1 clinical trial. Conditions studied include Epilepsy and Brain Diseases.

CMS Open Payments shows 85 general payments to Dr. McDermott from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Molnlycke Health Care US, LLC paid the most, $6,395.

Dmand AI lists 3 awards for Dr. McDermott, most recently CMS Stage 1 EHR in 2013.

Dr. McDermott graduated from University of Toronto Faculty of Medicine in 1982. Dr. McDermott is a member of AANS and CNS.

Dr. McDermott is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.